Solid Tumours

Oncology·MeSH: Carcinoma, Non-Small-Cell Lung

17 drugs in development·5 companies·5 clinical trials

Drug Pipeline by Phase

Phase 3(7)

Phase 2(3)

Drug	Company
azd1775	ASTRAZENECA PLC (AZN)
AZD9592	ASTRAZENECA PLC (AZN)
Cetrelimab	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(6)

Drug	Company
[111in]-fpi-1547	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection multi-dose	Fusion Pharmaceuticals Inc. (FUSN)
[225ac]-fpi-1434 injection single-dose	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1175 infusion	Fusion Pharmaceuticals Inc. (FUSN)
fpi-1434	Fusion Pharmaceuticals Inc. (FUSN)
PYX-201	Pyxis Oncology, Inc. (PYXS)

Phase 4(1)

Drug	Company
bms-986517	BRISTOL MYERS SQUIBB CO (BMY)

BioSniper tracks 17 drugs in development for Solid Tumours across 5 companies.

There are 5 clinical trials targeting Solid Tumours tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.